The latest lymphoma news
A growing repertoire of cell and molecule-based immunotherapies is offering patients with indomitable cancers new…
A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University…
A single infusion of chimeric antigen receptor T-cell (CAR-T) therapy induced complete response or remission…
Patient outcomes from an international cooperative clinical trial for advanced stage Hodgkin lymphoma show “the…
The Food and Drug Administration has granted accelerated approval to glofitamab-gxbm for relapsed or refractory…
A new research paper was published in Oncotarget’s Volume 14 on June 12, 2023, entitled, “LP-284, a…
In a multicenter phase 1 and 2 trial (BRUIN, NCT03740529), researchers from leading cancer centers…
Today, Blood Advances published a study revealing that patients with relapsed/refractory (r/r) lymphoma during pregnancy experienced a…
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric…
Results from the largest prospective study of primary mediastinal B-cell lymphoma show that radiation therapy…